ID   CPSF3_HUMAN             Reviewed;         684 AA.
AC   Q9UKF6; O14769; Q53RS2; Q96F36;
DT   18-OCT-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   22-JUL-2015, entry version 128.
DE   RecName: Full=Cleavage and polyadenylation specificity factor subunit 3;
DE            EC=3.1.27.-;
DE   AltName: Full=Cleavage and polyadenylation specificity factor 73 kDa subunit;
DE            Short=CPSF 73 kDa subunit;
DE   AltName: Full=mRNA 3'-end-processing endonuclease CPSF-73;
GN   Name=CPSF3; Synonyms=CPSF73;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Hepatoma;
RA   Yu S., Chen W., Pang X., Dong X., Wang H.;
RT   "Homo sapiens mRNA for CPSF (cleavage and polyadenylation specificity
RT   factor) 73 kDa subunit.";
RL   Submitted (JUL-1999) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT GLY-142.
RC   TISSUE=Brain, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 120-498.
RA   Pusch W.;
RT   "H. sapiens mRNA for the 73 kDa subunit of CPSF (cleavage and
RT   polyadenylation specificity factor, partial cds).";
RL   Submitted (AUG-1997) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   FUNCTION IN PRE-MRNA 3'-END PROCESSING, AND IDENTIFICATION IN THE CPSF
RP   COMPLEX.
RX   PubMed=14749727; DOI=10.1038/sj.emboj.7600070;
RA   Kaufmann I., Martin G., Friedlein A., Langen H., Keller W.;
RT   "Human Fip1 is a subunit of CPSF that binds to U-rich RNA elements and
RT   stimulates poly(A) polymerase.";
RL   EMBO J. 23:616-626(2004).
RN   [7]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=15037765; DOI=10.1261/rna.5214404;
RA   Ryan K., Calvo O., Manley J.L.;
RT   "Evidence that polyadenylation factor CPSF-73 is the mRNA 3'
RT   processing endonuclease.";
RL   RNA 10:565-573(2004).
RN   [8]
RP   SUMOYLATION AT LYS-462; LYS-465 AND LYS-545, AND MUTAGENESIS OF
RP   LYS-462; LYS-465 AND LYS-545.
RX   PubMed=17923699; DOI=10.1128/MCB.01186-07;
RA   Vethantham V., Rao N., Manley J.L.;
RT   "Sumoylation modulates the assembly and activity of the pre-mRNA 3'
RT   processing complex.";
RL   Mol. Cell. Biol. 27:8848-8858(2007).
RN   [9]
RP   FUNCTION, INTERACTION WITH CPSF2; CSTF2 AND SYMPK, AND MUTAGENESIS OF
RP   HIS-73; ASP-75; HIS-76; SER-334 AND HIS-396.
RX   PubMed=18688255; DOI=10.1038/embor.2008.146;
RA   Kolev N.G., Yario T.A., Benson E., Steitz J.A.;
RT   "Conserved motifs in both CPSF73 and CPSF100 are required to assemble
RT   the active endonuclease for histone mRNA 3'-end maturation.";
RL   EMBO Rep. 9:1013-1018(2008).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS], AND CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [11]
RP   INTERACTION WITH WDR33.
RX   PubMed=19217410; DOI=10.1016/j.molcel.2008.12.028;
RA   Shi Y., Di Giammartino D.C., Taylor D., Sarkeshik A., Rice W.J.,
RA   Yates J.R. III, Frank J., Manley J.L.;
RT   "Molecular architecture of the human pre-mRNA 3' processing complex.";
RL   Mol. Cell 33:365-376(2009).
RN   [12]
RP   IDENTIFICATION IN THE CPSF COMPLEX, AND INTERACTION WITH TUT1.
RX   PubMed=21102410; DOI=10.1038/emboj.2010.287;
RA   Laishram R.S., Anderson R.A.;
RT   "The poly A polymerase Star-PAP controls 3'-end cleavage by promoting
RT   CPSF interaction and specificity toward the pre-mRNA.";
RL   EMBO J. 29:4132-4145(2010).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-681, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS], AND CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 1-459 IN COMPLEX WITH ZINC
RP   IONS, FUNCTION, AND MUTAGENESIS OF 75-ASP-HIS-76.
RX   PubMed=17128255; DOI=10.1038/nature05363;
RA   Mandel C.R., Kaneko S., Zhang H., Gebauer D., Vethantham V.,
RA   Manley J.L., Tong L.;
RT   "Polyadenylation factor CPSF-73 is the pre-mRNA 3'-end-processing
RT   endonuclease.";
RL   Nature 444:953-956(2006).
RN   [18]
RP   VARIANT [LARGE SCALE ANALYSIS] ASN-578.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Component of the cleavage and polyadenylation
CC       specificity factor (CPSF) complex that play a key role in pre-mRNA
CC       3'-end formation, recognizing the AAUAAA signal sequence and
CC       interacting with poly(A) polymerase and other factors to bring
CC       about cleavage and poly(A) addition. Has endonuclease activity,
CC       and functions as mRNA 3'-end-processing endonuclease. Also
CC       involved in the histone 3'-end pre-mRNA processing. U7 snRNP-
CC       dependent protein that induces both the 3'-endoribonucleolytic
CC       cleavage of histone pre-mRNAs and acts as a 5' to 3' exonuclease
CC       for degrading the subsequent downstream cleavage product (DCP) of
CC       mature histone mRNAs. Cleavage occurs after the 5'-ACCCA-3'
CC       sequence in the histone pre-mRNA leaving a 3'hydroxyl group on the
CC       upstream fragment containing the stem loop (SL) and 5' phosphate
CC       on the downstream cleavage product (DCP) starting with CU
CC       nucleotides. The U7-dependent 5' to 3' exonuclease activity is
CC       processive and degrades the DCP RNA substrate even after complete
CC       removal of the U7-binding site. Binds to the downstream cleavage
CC       product (DCP) of histone pre-mRNAs and the cleaved DCP RNA
CC       substrate in a U7 snRNP dependent manner.
CC       {ECO:0000269|PubMed:14749727, ECO:0000269|PubMed:15037765,
CC       ECO:0000269|PubMed:17128255, ECO:0000269|PubMed:18688255}.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC       Note=Binds 2 Zn(2+) ions per subunit.;
CC   -!- SUBUNIT: Component of the cleavage and polyadenylation specificity
CC       factor (CPSF) complex, composed of CPSF1, CPSF2, CPSF3, CPSF4 and
CC       FIP1L1. Interacts with CPSF2, CSTF2 and SYMPK. Interacts with
CC       TUT1; the interaction is direct and mediates the recruitment of
CC       the CPSF complex on the 3'UTR of pre-mRNAs. Interacts with WDR33.
CC       {ECO:0000269|PubMed:14749727, ECO:0000269|PubMed:17128255,
CC       ECO:0000269|PubMed:18688255, ECO:0000269|PubMed:19217410,
CC       ECO:0000269|PubMed:21102410}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:15037765}.
CC   -!- PTM: Sumoylated on Lys-462, Lys-465 and Lys-545, preferentially by
CC       SUMO3. {ECO:0000269|PubMed:17923699}.
CC   -!- SIMILARITY: Belongs to the metallo-beta-lactamase superfamily.
CC       RNA-metabolizing metallo-beta-lactamase-like family. CPSF3
CC       subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF171877; AAF00224.1; -; mRNA.
DR   EMBL; AC080162; AAY14858.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAX00989.1; -; Genomic_DNA.
DR   EMBL; BC011654; AAH11654.1; -; mRNA.
DR   EMBL; BC020211; AAH20211.1; -; mRNA.
DR   EMBL; AF017269; AAB70268.1; -; mRNA.
DR   CCDS; CCDS1664.1; -.
DR   RefSeq; NP_057291.1; NM_016207.3.
DR   UniGene; Hs.515972; -.
DR   PDB; 2I7T; X-ray; 2.10 A; A=1-459.
DR   PDB; 2I7V; X-ray; 2.10 A; A=1-459.
DR   PDBsum; 2I7T; -.
DR   PDBsum; 2I7V; -.
DR   ProteinModelPortal; Q9UKF6; -.
DR   SMR; Q9UKF6; 7-459.
DR   BioGrid; 119680; 21.
DR   DIP; DIP-42501N; -.
DR   IntAct; Q9UKF6; 9.
DR   MINT; MINT-1742891; -.
DR   STRING; 9606.ENSP00000238112; -.
DR   PhosphoSite; Q9UKF6; -.
DR   BioMuta; CPSF3; -.
DR   DMDM; 18203503; -.
DR   MaxQB; Q9UKF6; -.
DR   PaxDb; Q9UKF6; -.
DR   PeptideAtlas; Q9UKF6; -.
DR   PRIDE; Q9UKF6; -.
DR   DNASU; 51692; -.
DR   Ensembl; ENST00000238112; ENSP00000238112; ENSG00000119203.
DR   GeneID; 51692; -.
DR   KEGG; hsa:51692; -.
DR   UCSC; uc002qzo.2; human.
DR   CTD; 51692; -.
DR   GeneCards; GC02P009563; -.
DR   HGNC; HGNC:2326; CPSF3.
DR   HPA; HPA034657; -.
DR   MIM; 606029; gene.
DR   neXtProt; NX_Q9UKF6; -.
DR   PharmGKB; PA26843; -.
DR   eggNOG; COG1236; -.
DR   GeneTree; ENSGT00780000121968; -.
DR   HOGENOM; HOG000203394; -.
DR   HOVERGEN; HBG051107; -.
DR   InParanoid; Q9UKF6; -.
DR   KO; K14403; -.
DR   OMA; EISFSAH; -.
DR   OrthoDB; EOG7BW0HT; -.
DR   PhylomeDB; Q9UKF6; -.
DR   TreeFam; TF105643; -.
DR   Reactome; REACT_1096; Processing of Intronless Pre-mRNAs.
DR   Reactome; REACT_1835; Transport of Mature mRNA Derived from an Intronless Transcript.
DR   Reactome; REACT_1849; mRNA 3'-end processing.
DR   Reactome; REACT_387; Cleavage of Growing Transcript in the Termination Region.
DR   Reactome; REACT_467; mRNA Splicing - Major Pathway.
DR   ChiTaRS; CPSF3; human.
DR   EvolutionaryTrace; Q9UKF6; -.
DR   GeneWiki; CPSF3; -.
DR   GenomeRNAi; 51692; -.
DR   NextBio; 55702; -.
DR   PRO; PR:Q9UKF6; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; Q9UKF6; -.
DR   CleanEx; HS_CPSF3; -.
DR   ExpressionAtlas; Q9UKF6; baseline and differential.
DR   Genevisible; Q9UKF6; HS.
DR   GO; GO:0005847; C:mRNA cleavage and polyadenylation specificity factor complex; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0030529; C:ribonucleoprotein complex; IEA:UniProtKB-KW.
DR   GO; GO:0008409; F:5'-3' exonuclease activity; ISS:UniProtKB.
DR   GO; GO:0004521; F:endoribonuclease activity; ISS:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0003723; F:RNA binding; ISS:UniProtKB.
DR   GO; GO:0010467; P:gene expression; TAS:Reactome.
DR   GO; GO:0006398; P:histone mRNA 3'-end processing; IDA:UniProtKB.
DR   GO; GO:0031124; P:mRNA 3'-end processing; TAS:Reactome.
DR   GO; GO:0006379; P:mRNA cleavage; TAS:ProtInc.
DR   GO; GO:0006406; P:mRNA export from nucleus; TAS:Reactome.
DR   GO; GO:0006378; P:mRNA polyadenylation; TAS:ProtInc.
DR   GO; GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome.
DR   GO; GO:0008380; P:RNA splicing; TAS:Reactome.
DR   GO; GO:0006369; P:termination of RNA polymerase II transcription; TAS:Reactome.
DR   GO; GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome.
DR   Gene3D; 3.60.15.10; -; 1.
DR   InterPro; IPR001279; Beta-lactamas-like.
DR   InterPro; IPR022712; Beta_Casp.
DR   InterPro; IPR021718; CPSF73-100_C.
DR   InterPro; IPR011108; RMMBL.
DR   Pfam; PF10996; Beta-Casp; 1.
DR   Pfam; PF11718; CPSF73-100_C; 1.
DR   Pfam; PF00753; Lactamase_B; 1.
DR   Pfam; PF07521; RMMBL; 1.
DR   SMART; SM01027; Beta-Casp; 1.
DR   SMART; SM01098; CPSF73-100_C; 1.
DR   SMART; SM00849; Lactamase_B; 1.
DR   SUPFAM; SSF56281; SSF56281; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome; Endonuclease; Hydrolase;
KW   Isopeptide bond; Metal-binding; mRNA processing; Nuclease; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome; Ribonucleoprotein;
KW   RNA-binding; Ubl conjugation; Zinc.
FT   INIT_MET      1      1       Removed. {ECO:0000269|PubMed:19413330,
FT                                ECO:0000269|PubMed:22223895}.
FT   CHAIN         2    684       Cleavage and polyadenylation specificity
FT                                factor subunit 3.
FT                                /FTId=PRO_0000074400.
FT   ACT_SITE    396    396       Proton donor. {ECO:0000255}.
FT   METAL        71     71       Zinc 1.
FT   METAL        73     73       Zinc 1.
FT   METAL        75     75       Zinc 2.
FT   METAL        76     76       Zinc 2.
FT   METAL       158    158       Zinc 1.
FT   METAL       179    179       Zinc 1.
FT   METAL       179    179       Zinc 2.
FT   METAL       418    418       Zinc 2.
FT   MOD_RES       2      2       N-acetylserine.
FT                                {ECO:0000269|PubMed:19413330,
FT                                ECO:0000269|PubMed:22223895}.
FT   MOD_RES     681    681       Phosphothreonine.
FT                                {ECO:0000269|PubMed:20068231}.
FT   CROSSLNK    462    462       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO).
FT   CROSSLNK    465    465       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO).
FT   CROSSLNK    545    545       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO).
FT   VARIANT     142    142       E -> G (in dbSNP:rs17850770).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_037646.
FT   VARIANT     578    578       D -> N (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035873.
FT   MUTAGEN      73     73       H->A: Inhibits histone 3'-end processing.
FT                                {ECO:0000269|PubMed:18688255}.
FT   MUTAGEN      75     76       DH->KA: Loss of histone 3'-end
FT                                processing.
FT                                {ECO:0000269|PubMed:17128255}.
FT   MUTAGEN      75     75       D->A: Inhibits histone 3'-end processing.
FT                                {ECO:0000269|PubMed:18688255}.
FT   MUTAGEN      76     76       H->A: Inhibits histone 3'-end processing.
FT                                {ECO:0000269|PubMed:18688255}.
FT   MUTAGEN     334    334       S->A: Does not inhibit histone 3'-end
FT                                processing.
FT                                {ECO:0000269|PubMed:18688255}.
FT   MUTAGEN     396    396       H->A: Inhibits histone 3'-end processing.
FT                                {ECO:0000269|PubMed:18688255}.
FT   MUTAGEN     462    462       K->R: Reduced sumoylation; when
FT                                associated with R-465 and R-545.
FT                                {ECO:0000269|PubMed:17923699}.
FT   MUTAGEN     465    465       K->R: Reduced sumoylation; when
FT                                associated with R-462 and R-545.
FT                                {ECO:0000269|PubMed:17923699}.
FT   MUTAGEN     545    545       K->R: Reduced sumoylation; when
FT                                associated with R-462 and R-465.
FT                                {ECO:0000269|PubMed:17923699}.
FT   STRAND       10     25       {ECO:0000244|PDB:2I7T}.
FT   STRAND       27     32       {ECO:0000244|PDB:2I7T}.
FT   STRAND       35     39       {ECO:0000244|PDB:2I7T}.
FT   HELIX        49     52       {ECO:0000244|PDB:2I7T}.
FT   HELIX        56     58       {ECO:0000244|PDB:2I7T}.
FT   HELIX        61     63       {ECO:0000244|PDB:2I7T}.
FT   STRAND       66     68       {ECO:0000244|PDB:2I7T}.
FT   HELIX        74     77       {ECO:0000244|PDB:2I7T}.
FT   HELIX        80     86       {ECO:0000244|PDB:2I7T}.
FT   STRAND       91     96       {ECO:0000244|PDB:2I7T}.
FT   HELIX        97    110       {ECO:0000244|PDB:2I7T}.
FT   HELIX       125    131       {ECO:0000244|PDB:2I7T}.
FT   HELIX       132    134       {ECO:0000244|PDB:2I7T}.
FT   STRAND      135    138       {ECO:0000244|PDB:2I7T}.
FT   STRAND      144    146       {ECO:0000244|PDB:2I7T}.
FT   STRAND      149    155       {ECO:0000244|PDB:2I7T}.
FT   STRAND      163    169       {ECO:0000244|PDB:2I7T}.
FT   STRAND      172    176       {ECO:0000244|PDB:2I7T}.
FT   STRAND      186    188       {ECO:0000244|PDB:2I7V}.
FT   STRAND      199    204       {ECO:0000244|PDB:2I7T}.
FT   TURN        206    209       {ECO:0000244|PDB:2I7T}.
FT   HELIX       215    231       {ECO:0000244|PDB:2I7T}.
FT   STRAND      235    239       {ECO:0000244|PDB:2I7T}.
FT   STRAND      242    245       {ECO:0000244|PDB:2I7T}.
FT   HELIX       246    259       {ECO:0000244|PDB:2I7T}.
FT   HELIX       261    263       {ECO:0000244|PDB:2I7T}.
FT   STRAND      268    271       {ECO:0000244|PDB:2I7T}.
FT   HELIX       275    284       {ECO:0000244|PDB:2I7V}.
FT   TURN        285    287       {ECO:0000244|PDB:2I7V}.
FT   STRAND      307    310       {ECO:0000244|PDB:2I7T}.
FT   HELIX       314    316       {ECO:0000244|PDB:2I7V}.
FT   STRAND      321    328       {ECO:0000244|PDB:2I7T}.
FT   HELIX       335    344       {ECO:0000244|PDB:2I7T}.
FT   STRAND      351    354       {ECO:0000244|PDB:2I7T}.
FT   HELIX       363    367       {ECO:0000244|PDB:2I7T}.
FT   STRAND      372    375       {ECO:0000244|PDB:2I7T}.
FT   STRAND      381    383       {ECO:0000244|PDB:2I7T}.
FT   STRAND      386    390       {ECO:0000244|PDB:2I7T}.
FT   HELIX       399    409       {ECO:0000244|PDB:2I7T}.
FT   STRAND      412    419       {ECO:0000244|PDB:2I7T}.
FT   HELIX       421    435       {ECO:0000244|PDB:2I7T}.
FT   STRAND      444    446       {ECO:0000244|PDB:2I7T}.
FT   STRAND      454    458       {ECO:0000244|PDB:2I7T}.
SQ   SEQUENCE   684 AA;  77486 MW;  F8AA24EA6FB78377 CRC64;
     MSAIPAEESD QLLIRPLGAG QEVGRSCIIL EFKGRKIMLD CGIHPGLEGM DALPYIDLID
     PAEIDLLLIS HFHLDHCGAL PWFLQKTSFK GRTFMTHATK AIYRWLLSDY VKVSNISADD
     MLYTETDLEE SMDKIETINF HEVKEVAGIK FWCYHAGHVL GAAMFMIEIA GVKLLYTGDF
     SRQEDRHLMA AEIPNIKPDI LIIESTYGTH IHEKREEREA RFCNTVHDIV NRGGRGLIPV
     FALGRAQELL LILDEYWQNH PELHDIPIYY ASSLAKKCMA VYQTYVNAMN DKIRKQININ
     NPFVFKHISN LKSMDHFDDI GPSVVMASPG MMQSGLSREL FESWCTDKRN GVIIAGYCVE
     GTLAKHIMSE PEEITTMSGQ KLPLKMSVDY ISFSAHTDYQ QTSEFIRALK PPHVILVHGE
     QNEMARLKAA LIREYEDNDE VHIEVHNPRN TEAVTLNFRG EKLAKVMGFL ADKKPEQGQR
     VSGILVKRNF NYHILSPCDL SNYTDLAMST VKQTQAIPYT GPFNLLCYQL QKLTGDVEEL
     EIQEKPALKV FKNITVIQEP GMVVLEWLAN PSNDMYADTV TTVILEVQSN PKIRKGAVQK
     VSKKLEMHVY SKRLEIMLQD IFGEDCVSVK DDSILSVTVD GKTANLNLET RTVECEEGSE
     DDESLREMVE LAAQRLYEAL TPVH
//
